(Total Views: 324)
Posted On: 09/17/2020 12:26:55 PM
Post# of 107
$PVCT News Article - Provectus Biopharmaceuticals Announces Presentation of Preliminary Data from Combination Therapy Trial of PV-10 and KEYTRUDA for Checkpoint-Refractory Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020 https://marketwirenews.com/news-releases/prov...75250.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
